Drug discovery is slow, expensive, and prone to failure because promising targets and responsive patient groups are difficult to identify early.
R&D Focus
AI-assisted target discovery and drug development
Innovative Solution
BAINOM offers a hybrid data analytics platform that allows R&D companies, healthcare professionals, and researchers to turn multi-omic, multi-modal data into clinical insights that drives drug discovery, precision medicine, and biomedical research.
Investment Funding
Last Funding Stage
Pre-Seed
Last Funding Date
02-08-2022
Startup Stage
Seed
Lead Investors
XLerateHealth
Revenue
Less than $1M
People
Founders
Deepak Sharma
Eckhard Jankowsky
About
BAINOM offers a hybrid data analytics platform that allows R&D companies, healthcare professionals, and researchers to turn multi-omic, multi-modal data into clinical insights that drives drug discovery, precision medicine, and biomedical research. BAINOM achieves this through a cutting-edge fusion of customized bioinformatics as a service, ML-driven deep-mining of the multi-omic dataspace, and automated AI-based cloud computing workflows.
Products
Demo Product or Complete Product?
Development stage
Something missing or incorrect on this page? Help us enrich this information
